Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task

Rationale Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version...

Full description

Saved in:
Bibliographic Details
Published inPsychopharmacology Vol. 234; no. 4; pp. 613 - 620
Main Authors Rychlik, Michal, Bollen, Eva, Rygula, Rafal
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2017
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rationale Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants. Objectives In the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties—ketamine (KET)—on the sensitivity of rats to positive and negative feedback in the PRL paradigm. Methods We trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration. Results We report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose–shift responses made by rats after receiving negative feedback. Conclusion Present results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.
AbstractList Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants. In the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties-ketamine (KET)-on the sensitivity of rats to positive and negative feedback in the PRL paradigm. We trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration. We report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose-shift responses made by rats after receiving negative feedback. Present results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.
Rationale Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants. Objectives In the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties—ketamine (KET)—on the sensitivity of rats to positive and negative feedback in the PRL paradigm. Methods We trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration. Results We report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose–shift responses made by rats after receiving negative feedback. Conclusion Present results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.
Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants. In the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties-ketamine (KET)-on the sensitivity of rats to positive and negative feedback in the PRL paradigm. We trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration. We report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose-shift responses made by rats after receiving negative feedback. Present results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.
Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants.RATIONALEDepression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants.In the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties-ketamine (KET)-on the sensitivity of rats to positive and negative feedback in the PRL paradigm.OBJECTIVESIn the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties-ketamine (KET)-on the sensitivity of rats to positive and negative feedback in the PRL paradigm.We trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration.METHODSWe trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration.We report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose-shift responses made by rats after receiving negative feedback.RESULTSWe report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose-shift responses made by rats after receiving negative feedback.Present results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.CONCLUSIONPresent results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.
Rationale Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the probabilistic reversal-learning (PRL) task. This task was initially designed for clinical research, but introduction of its rodent version provides a new and much needed translational paradigm to evaluate potential novel antidepressants. Objectives In the present study, we aimed at evaluating the effects of a compound showing clear antidepressant properties-ketamine (KET)-on the sensitivity of rats to positive and negative feedback in the PRL paradigm. Methods We trained healthy rats in an operant version of the PRL task. For successful completion of the task, subjects had to learn to ignore infrequent and misleading feedback, arising from the probabilistic (80:20) nature of the discrimination. Subsequently, we evaluated the effect of KET (5, 10, and 20 mg/kg) on feedback sensitivity 1, 24, and 48 h after administration. Results We report that acute administration of the highest dose of KET (20 mg/kg) rapidly and persistently decreases the proportion of lose-shift responses made by rats after receiving negative feedback. Conclusion Present results suggest that KET decreases negative feedback sensitivity and that changes in this basic neurocognitive function might be one of the factors responsible for its antidepressant action.
Audience Academic
Author Bollen, Eva
Rychlik, Michal
Rygula, Rafal
Author_xml – sequence: 1
  givenname: Michal
  surname: Rychlik
  fullname: Rychlik, Michal
  organization: Institute of Pharmacology, Polish Academy of Sciences, Department of Behavioral Neuroscience and Drug Development, Affective Cognitive Neuroscience Laboratory
– sequence: 2
  givenname: Eva
  surname: Bollen
  fullname: Bollen, Eva
  organization: Institute of Pharmacology, Polish Academy of Sciences, Department of Behavioral Neuroscience and Drug Development, Affective Cognitive Neuroscience Laboratory
– sequence: 3
  givenname: Rafal
  surname: Rygula
  fullname: Rygula, Rafal
  email: rygula@gmail.com
  organization: Institute of Pharmacology, Polish Academy of Sciences, Department of Behavioral Neuroscience and Drug Development, Affective Cognitive Neuroscience Laboratory
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27933365$$D View this record in MEDLINE/PubMed
BookMark eNqNks1u1DAUhS1URKeFB2CDLLFhk2LH8d8GqaqAIiqxgbXl2DeD28Qe7MxIffs6mra0FSCchaX4Oye-J-cIHcQUAaHXlJxQQuT7QkhLWUOoaLpOy4Y-QyvasbZpiWwP0IoQxhpGuTpER6Vckro61b1Ah63UjDHBV2j7FWY7hQjYg8tgCxRcIJYwh12Yr3Ea8GRHwNnOBc8JT6GMYH2IaxxhbSsFeADwvXVXOERs8San3vZhDGUODmfYQS52bKoqx0U223L1Ej0f7Fjg1e1-jH58-vj97Ly5-Pb5y9npReO4JHMdwwnJiVaUauqJGAYNWpNeeul6L7Tk0mrvrWiVtp51Amhfx1diENY72bFj9GHvu9n2E3gHcc52NJscJpuvTbLBPD6J4adZp53hrWAtUdXg3a1BTr-2UGZTA3AwjjZC2hZDlVCMKNKR_0A7qTTjVFb07RP0Mm1zrEkshrzllCnxm1rXH2BCHFK9oltMzSnnlDDStYvXyR-o-niYgqt9GUJ9_0jw5mEm92HcdaICdA-4nErJMNwjlJild2bfO1N7Z5beGVo18onGhbm2Iy2xhvGfynavLPUrcQ35QRZ_Fd0AqDzrRQ
CitedBy_id crossref_primary_10_1007_s00213_023_06514_4
crossref_primary_10_3390_cells10113157
crossref_primary_10_1007_s00213_022_06273_8
crossref_primary_10_1093_ijnp_pyaf010
crossref_primary_10_1007_s00213_023_06443_2
crossref_primary_10_1016_j_neubiorev_2018_10_008
crossref_primary_10_7554_eLife_87529_3
crossref_primary_10_1111_bph_17370
crossref_primary_10_7554_eLife_87529
crossref_primary_10_1159_000517074
crossref_primary_10_1016_j_cobeha_2018_05_001
crossref_primary_10_1111_bph_15613
crossref_primary_10_1007_s00213_018_5062_x
crossref_primary_10_1016_j_bbr_2018_10_003
crossref_primary_10_3389_fnbeh_2020_00147
crossref_primary_10_1177_2398212820907177
crossref_primary_10_1007_s00213_019_05333_w
crossref_primary_10_3389_fpsyt_2023_1170541
crossref_primary_10_3758_s13415_024_01171_2
crossref_primary_10_1016_j_euroneuro_2020_12_004
Cites_doi 10.1002/da.22501
10.1016/j.euroneuro.2013.03.002
10.1126/science.275.5306.1593
10.1523/JNEUROSCI.5058-13.2014
10.1176/appi.ajp.2009.09020149
10.1016/j.psyneuen.2010.05.003
10.1016/j.neubiorev.2016.05.007
10.1038/npp.2009.233
10.1016/j.neubiorev.2015.06.015
10.1001/archpsyc.63.8.856
10.1016/j.neuropharm.2012.07.025
10.1111/j.1749-6632.2012.06669.x
10.1016/j.ejphar.2014.07.046
10.1038/npp.2011.183
10.1016/S0091-3057(01)00693-1
10.1016/j.schres.2007.03.010
10.1016/j.euroneuro.2009.08.001
10.1016/j.biopsych.2010.01.027
10.1073/pnas.1014269108
10.3109/03009734.2012.724118
10.1523/JNEUROSCI.3366-15.2016
10.1038/npp.2014.298
10.1016/j.neuropharm.2015.10.034
10.3389/neuro.06.013.2009
10.1017/S0033291702007018
10.1016/j.pnpbp.2011.05.010
10.1176/appi.ajp.160.5.990
10.1007/s00213-010-2102-6
10.1017/S1461145714000649
10.1007/s00213-008-1158-z
10.1016/j.biopsych.2014.04.014
10.1016/j.neuroimage.2008.05.049
10.1016/j.jaac.2016.01.007
10.2174/13816128113199990293
10.1016/j.biopsych.2009.08.038
10.1016/j.neuroscience.2009.07.033
10.1055/s-2007-979537
10.1016/j.pnpbp.2007.07.027
10.1016/j.tips.2009.09.002
10.31887/DCNS.2012.14.1/smorris
10.1523/JNEUROSCI.22-11-04563.2002
ContentType Journal Article
Copyright The Author(s) 2016
COPYRIGHT 2017 Springer
Psychopharmacology is a copyright of Springer, 2017.
Copyright_xml – notice: The Author(s) 2016
– notice: COPYRIGHT 2017 Springer
– notice: Psychopharmacology is a copyright of Springer, 2017.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
88G
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
K9.
KB0
M0S
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1007/s00213-016-4497-1
DatabaseName SpringerOpen
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database (ProQuest)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Medical Database
Psychology Database (ProQuest)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


Neurosciences Abstracts
MEDLINE - Academic

ProQuest One Psychology
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 620
ExternalDocumentID PMC5263208
4312364011
A551030427
27933365
10_1007_s00213_016_4497_1
Genre Journal Article
GrantInformation_xml – fundername: Polish National Science Centre
  grantid: OPUS-2014/13/B/NZ4/00214
– fundername: ;
  grantid: OPUS-2014/13/B/NZ4/00214
GroupedDBID -4W
-BR
.55
3SX
40D
40E
95.
95~
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
C6C
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
AAYXX
CITATION
---
-Y2
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2QV
2VQ
2~H
30V
36B
3O-
4.4
406
408
409
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTAH
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACNCT
ACOKC
ACOMO
ACPIV
ACPRK
ACUHS
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDZB
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
B-.
B0M
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
DXH
EAD
EAP
EBC
EBD
EBLON
EBS
ECM
EIF
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EN4
EPAXT
EPL
EPS
ESBYG
ESX
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
ICJ
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
INR
IPY
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M2M
M4Y
MA-
MK0
N9A
NAPCQ
NB0
NDZJH
NPM
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF-
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TN5
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UAP
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WIP
WJK
WK6
WK8
WOW
XOL
YLTOR
YQJ
YYP
Z45
ZGI
ZMTXR
ZOVNA
ZY4
~8M
3V.
7QG
7QR
7TK
7XB
8FD
8FK
FR3
K9.
P64
PHGZM
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
ABFSG
ABRTQ
ACSTC
AEZWR
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
5PM
ID FETCH-LOGICAL-c570t-20c6750981191d06ff9e990b7d7cbd69757a9dda6289ad346e1b43286f6adc743
IEDL.DBID 7X7
ISSN 0033-3158
1432-2072
IngestDate Thu Aug 21 14:35:43 EDT 2025
Fri Jul 11 13:36:38 EDT 2025
Mon Jul 21 10:07:45 EDT 2025
Sat Aug 16 09:21:08 EDT 2025
Wed Mar 19 01:30:48 EDT 2025
Sat Mar 08 18:23:50 EST 2025
Tue Apr 08 05:56:59 EDT 2025
Tue Jul 01 04:16:50 EDT 2025
Thu Apr 24 23:00:03 EDT 2025
Fri Feb 21 02:34:12 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Animal model
Feedback sensitivity
Probabilistic reversal learning
Ketamine
Rat
Language English
License Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c570t-20c6750981191d06ff9e990b7d7cbd69757a9dda6289ad346e1b43286f6adc743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1007/s00213-016-4497-1
PMID 27933365
PQID 1865251386
PQPubID 47309
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5263208
proquest_miscellaneous_1868308040
proquest_miscellaneous_1847893517
proquest_journals_1865251386
gale_infotracmisc_A551030427
gale_infotracacademiconefile_A551030427
pubmed_primary_27933365
crossref_primary_10_1007_s00213_016_4497_1
crossref_citationtrail_10_1007_s00213_016_4497_1
springer_journals_10_1007_s00213_016_4497_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-02-01
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: 2017-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Psychopharmacology
PublicationTitleAbbrev Psychopharmacology
PublicationTitleAlternate Psychopharmacology (Berl)
PublicationYear 2017
Publisher Springer Berlin Heidelberg
Springer
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer
– name: Springer Nature B.V
References Cools, Clark, Owen, Robbins (CR6) 2002; 22
Eshel, Roiser (CR10) 2010; 68
Garcia, Comim, Valvassori, Reus, Barbosa, Andreazza, Stertz, Fries, Gavioli, Kapczinski, Quevedo (CR11) 2008; 32
Harmer, Hill, Taylor, Cowen, Goodwin (CR14) 2003; 160
Waltz, Gold (CR38) 2007; 93
Zarate, Singh, Carlson, Brutsche, Ameli, Luckenbaugh, Charney, Manji (CR41) 2006; 63
Bari, Theobald, Caprioli, Mar, Aidoo-Micah, Dalley, Robbins (CR3) 2010; 35
Belujon, Grace (CR4) 2014; 76
Nikiforuk, Golembiowska, Popik (CR23) 2010; 20
Kos, Nikiforuk, Rafa, Popik (CR18) 2011; 214
Skolnick, Layer, Popik, Nowak, Paul, Trullas (CR35) 1996; 29
Ineichen, Sigrist, Spinelli, Lesch, Sautter, Seifritz, Pryce (CR16) 2012; 63
Yilmaz, Schulz, Aksoy, Canbeyli (CR40) 2002; 71
Morris, Cuthbert (CR20) 2012; 14
Peterson, Elliott, Song, Makeig, Sejnowski, Poizner (CR27) 2009; 163
aan het Rot, Collins, Murrough, Perez, Reich, Charney, Mathew (CR1) 2010; 67
Bjorkholm, Monteggia (CR5) 2016; 102
Dinan, Cryan (CR26) 2015; 753
Pryce, Seifritz (CR29) 2011; 36
Serafini, Pompili, Innamorati, Dwivedi, Brahmachari, Girardi (CR34) 2013; 19
Nilsson, Alsio, Somerville, Clifton (CR24) 2015; 56
Dalton, Wang, Phillips, Floresco (CR8) 2016; 36
Harmer, O’Sullivan, Favaron, Massey-Chase, Ayres, Reinecke, Goodwin, Cowen (CR15) 2009; 166
Luking, Pagliaccio, Luby, Barch (CR19) 2016; 55
Yang, Hu, Zhou, Zhang, Yang (CR39) 2013; 118
Taylor Tavares, Clark, Furey, Williams, Sahakian, Drevets (CR37) 2008; 42
Glimcher (CR13) 2011; 108
Murrough, Burdick, Levitch, Perez, Brallier, Chang, Foulkes, Charney, Mathew, Iosifescu (CR22) 2015; 40
Quirk, Sosulski, Feierstein, Uchida, Mainen (CR30) 2009; 3
Rolls (CR32) 2016; 68
Dzirasa, Covington (CR9) 2012; 1265
Skolnick, Popik, Trullas (CR36) 2009; 30
Gastambide, Mitchell, Robbins, Tricklebank, Gilmour (CR12) 2013; 23
Schultz, Dayan, Montague (CR33) 1997; 275
Dalton, Phillips, Floresco (CR7) 2014; 34
Jernigan, Goswami, Austin, Iyo, Chandran, Stockmeier, Karolewicz (CR17) 2011; 35
Murphy, Michael, Robbins, Sahakian (CR21) 2003; 33
Roiser, Elliott, Sahakian (CR31) 2012; 37
Nishitani, Nagayasu, Asaoka, Yamashiro, Shirakawa, Nakagawa, Kaneko (CR25) 2014; 17
Abdallah, Adams, Kelmendi, Esterlis, Sanacora, Krystal (CR2) 2016; 33
Popik, Kos, Sowa-Kucma, Nowak (CR28) 2008; 198
G Serafini (4497_CR34) 2013; 19
P Skolnick (4497_CR35) 1996; 29
CJ Harmer (4497_CR14) 2003; 160
FC Murphy (4497_CR21) 2003; 33
A Bari (4497_CR3) 2010; 35
JV Taylor Tavares (4497_CR37) 2008; 42
GL Dalton (4497_CR7) 2014; 34
KR Luking (4497_CR19) 2016; 55
ET Rolls (4497_CR32) 2016; 68
PW Glimcher (4497_CR13) 2011; 108
GL Dalton (4497_CR8) 2016; 36
M Rot aan het (4497_CR1) 2010; 67
T Kos (4497_CR18) 2011; 214
P Belujon (4497_CR4) 2014; 76
LS Garcia (4497_CR11) 2008; 32
JW Murrough (4497_CR22) 2015; 40
DA Peterson (4497_CR27) 2009; 163
CR Pryce (4497_CR29) 2011; 36
C Yang (4497_CR39) 2013; 118
K Dzirasa (4497_CR9) 2012; 1265
N Eshel (4497_CR10) 2010; 68
CA Zarate Jr (4497_CR41) 2006; 63
C Bjorkholm (4497_CR5) 2016; 102
MC Quirk (4497_CR30) 2009; 3
TG Dinan (4497_CR26) 2015; 753
CG Abdallah (4497_CR2) 2016; 33
P Skolnick (4497_CR36) 2009; 30
CS Jernigan (4497_CR17) 2011; 35
C Ineichen (4497_CR16) 2012; 63
SE Morris (4497_CR20) 2012; 14
A Nikiforuk (4497_CR23) 2010; 20
R Cools (4497_CR6) 2002; 22
A Yilmaz (4497_CR40) 2002; 71
F Gastambide (4497_CR12) 2013; 23
CJ Harmer (4497_CR15) 2009; 166
P Popik (4497_CR28) 2008; 198
JA Waltz (4497_CR38) 2007; 93
JP Roiser (4497_CR31) 2012; 37
W Schultz (4497_CR33) 1997; 275
SR Nilsson (4497_CR24) 2015; 56
N Nishitani (4497_CR25) 2014; 17
References_xml – volume: 33
  start-page: 689
  year: 2016
  end-page: 697
  ident: CR2
  article-title: Ketamine’s mechanism of action: a path to rapid-acting antidepressants
  publication-title: Depression and anxiety
  doi: 10.1002/da.22501
– volume: 23
  start-page: 1414
  year: 2013
  end-page: 1422
  ident: CR12
  article-title: Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2013.03.002
– volume: 275
  start-page: 1593
  year: 1997
  end-page: 1599
  ident: CR33
  article-title: A neural substrate of prediction and reward
  publication-title: Science
  doi: 10.1126/science.275.5306.1593
– volume: 34
  start-page: 4618
  year: 2014
  end-page: 4626
  ident: CR7
  article-title: Preferential involvement by nucleus accumbens shell in mediating probabilistic learning and reversal shifts
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5058-13.2014
– volume: 166
  start-page: 1178
  year: 2009
  end-page: 1184
  ident: CR15
  article-title: Effect of acute antidepressant administration on negative affective bias in depressed patients
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2009.09020149
– volume: 36
  start-page: 308
  year: 2011
  end-page: 329
  ident: CR29
  article-title: A translational research framework for enhanced validity of mouse models of psychopathological states in depression
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2010.05.003
– volume: 68
  start-page: 47
  year: 2016
  end-page: 58
  ident: CR32
  article-title: A non-reward attractor theory of depression
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2016.05.007
– volume: 35
  start-page: 1290
  year: 2010
  end-page: 1301
  ident: CR3
  article-title: Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.233
– volume: 56
  start-page: 1
  year: 2015
  end-page: 14
  ident: CR24
  article-title: The rat’s not for turning: dissociating the psychological components of cognitive inflexibility
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2015.06.015
– volume: 63
  start-page: 856
  year: 2006
  end-page: 864
  ident: CR41
  article-title: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.63.8.856
– volume: 63
  start-page: 1012
  year: 2012
  end-page: 1021
  ident: CR16
  article-title: Establishing a probabilistic reversal learning test in mice: evidence for the processes mediating reward-stay and punishment-shift behaviour and for their modulation by serotonin
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2012.07.025
– volume: 14
  start-page: 29
  year: 2012
  end-page: 37
  ident: CR20
  article-title: Research domain criteria: cognitive systems, neural circuits, and dimensions of behavior
  publication-title: Dialogues Clin Neurosci
– volume: 1265
  start-page: 36
  year: 2012
  end-page: 45
  ident: CR9
  article-title: Increasing the validity of experimental models for depression
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2012.06669.x
– volume: 753
  start-page: 32
  year: 2015
  end-page: 50
  ident: CR26
  article-title: Faster, better, stronger: towards new antidepressant therapeutic strategies
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2014.07.046
– volume: 37
  start-page: 117
  year: 2012
  end-page: 136
  ident: CR31
  article-title: Cognitive mechanisms of treatment in depression
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.183
– volume: 71
  start-page: 341
  year: 2002
  end-page: 344
  ident: CR40
  article-title: Prolonged effect of an anesthetic dose of ketamine on behavioral despair
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/S0091-3057(01)00693-1
– volume: 93
  start-page: 296
  year: 2007
  end-page: 303
  ident: CR38
  article-title: Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.03.010
– volume: 20
  start-page: 37
  year: 2010
  end-page: 48
  ident: CR23
  article-title: Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2009.08.001
– volume: 68
  start-page: 118
  year: 2010
  end-page: 124
  ident: CR10
  article-title: Reward and punishment processing in depression
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.01.027
– volume: 108
  start-page: 15647
  issue: Suppl 3
  year: 2011
  end-page: 15654
  ident: CR13
  article-title: Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1014269108
– volume: 118
  start-page: 3
  year: 2013
  end-page: 8
  ident: CR39
  article-title: Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test
  publication-title: Ups J Med Sci
  doi: 10.3109/03009734.2012.724118
– volume: 36
  start-page: 1996
  year: 2016
  end-page: 2006
  ident: CR8
  article-title: Multifaceted contributions by different regions of the orbitofrontal and medial prefrontal cortex to probabilistic reversal learning
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3366-15.2016
– volume: 40
  start-page: 1084
  year: 2015
  end-page: 1090
  ident: CR22
  article-title: Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.298
– volume: 102
  start-page: 72
  year: 2016
  end-page: 79
  ident: CR5
  article-title: BDNF—a key transducer of antidepressant effects
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2015.10.034
– volume: 3
  start-page: 13
  year: 2009
  ident: CR30
  article-title: A defined network of fast-spiking interneurons in orbitofrontal cortex: responses to behavioral contingencies and ketamine administration
  publication-title: Front Syst Neurosci
  doi: 10.3389/neuro.06.013.2009
– volume: 22
  start-page: 4563
  year: 2002
  end-page: 4567
  ident: CR6
  article-title: Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging
  publication-title: J Neurosci
– volume: 33
  start-page: 455
  year: 2003
  end-page: 467
  ident: CR21
  article-title: Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance
  publication-title: Psychol Med
  doi: 10.1017/S0033291702007018
– volume: 35
  start-page: 1774
  year: 2011
  end-page: 1779
  ident: CR17
  article-title: The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2011.05.010
– volume: 160
  start-page: 990
  year: 2003
  end-page: 992
  ident: CR14
  article-title: Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.160.5.990
– volume: 214
  start-page: 911
  year: 2011
  end-page: 921
  ident: CR18
  article-title: The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-010-2102-6
– volume: 17
  start-page: 1321
  year: 2014
  end-page: 1326
  ident: CR25
  article-title: Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145714000649
– volume: 198
  start-page: 421
  year: 2008
  end-page: 430
  ident: CR28
  article-title: Lack of persistent effects of ketamine in rodent models of depression
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-008-1158-z
– volume: 76
  start-page: 927
  year: 2014
  end-page: 936
  ident: CR4
  article-title: Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2014.04.014
– volume: 42
  start-page: 1118
  year: 2008
  end-page: 1126
  ident: CR37
  article-title: Neural basis of abnormal response to negative feedback in unmedicated mood disorders
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2008.05.049
– volume: 55
  start-page: 328
  year: 2016
  end-page: 337
  ident: CR19
  article-title: Depression risk predicts blunted neural responses to gains and enhanced responses to losses in healthy children
  publication-title: J Am Acad Child Adolesc Psychiatry
  doi: 10.1016/j.jaac.2016.01.007
– volume: 19
  start-page: 1898
  year: 2013
  end-page: 1922
  ident: CR34
  article-title: Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression
  publication-title: Curr Pharm Des
  doi: 10.2174/13816128113199990293
– volume: 67
  start-page: 139
  year: 2010
  end-page: 145
  ident: CR1
  article-title: Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.08.038
– volume: 163
  start-page: 1092
  year: 2009
  end-page: 1101
  ident: CR27
  article-title: Probabilistic reversal learning is impaired in Parkinson’s disease
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.07.033
– volume: 29
  start-page: 23
  year: 1996
  end-page: 26
  ident: CR35
  article-title: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression
  publication-title: Pharmacopsychiatry
  doi: 10.1055/s-2007-979537
– volume: 32
  start-page: 140
  year: 2008
  end-page: 144
  ident: CR11
  article-title: Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2007.07.027
– volume: 30
  start-page: 563
  year: 2009
  end-page: 569
  ident: CR36
  article-title: Glutamate-based antidepressants: 20 years on
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2009.09.002
– volume: 198
  start-page: 421
  year: 2008
  ident: 4497_CR28
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-008-1158-z
– volume: 40
  start-page: 1084
  year: 2015
  ident: 4497_CR22
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.298
– volume: 163
  start-page: 1092
  year: 2009
  ident: 4497_CR27
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.07.033
– volume: 275
  start-page: 1593
  year: 1997
  ident: 4497_CR33
  publication-title: Science
  doi: 10.1126/science.275.5306.1593
– volume: 35
  start-page: 1290
  year: 2010
  ident: 4497_CR3
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.233
– volume: 36
  start-page: 1996
  year: 2016
  ident: 4497_CR8
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3366-15.2016
– volume: 63
  start-page: 856
  year: 2006
  ident: 4497_CR41
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.63.8.856
– volume: 67
  start-page: 139
  year: 2010
  ident: 4497_CR1
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.08.038
– volume: 108
  start-page: 15647
  issue: Suppl 3
  year: 2011
  ident: 4497_CR13
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1014269108
– volume: 29
  start-page: 23
  year: 1996
  ident: 4497_CR35
  publication-title: Pharmacopsychiatry
  doi: 10.1055/s-2007-979537
– volume: 32
  start-page: 140
  year: 2008
  ident: 4497_CR11
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2007.07.027
– volume: 1265
  start-page: 36
  year: 2012
  ident: 4497_CR9
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2012.06669.x
– volume: 76
  start-page: 927
  year: 2014
  ident: 4497_CR4
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2014.04.014
– volume: 56
  start-page: 1
  year: 2015
  ident: 4497_CR24
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2015.06.015
– volume: 20
  start-page: 37
  year: 2010
  ident: 4497_CR23
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2009.08.001
– volume: 37
  start-page: 117
  year: 2012
  ident: 4497_CR31
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.183
– volume: 68
  start-page: 47
  year: 2016
  ident: 4497_CR32
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2016.05.007
– volume: 102
  start-page: 72
  year: 2016
  ident: 4497_CR5
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2015.10.034
– volume: 35
  start-page: 1774
  year: 2011
  ident: 4497_CR17
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2011.05.010
– volume: 14
  start-page: 29
  year: 2012
  ident: 4497_CR20
  publication-title: Dialogues Clin Neurosci
  doi: 10.31887/DCNS.2012.14.1/smorris
– volume: 33
  start-page: 455
  year: 2003
  ident: 4497_CR21
  publication-title: Psychol Med
  doi: 10.1017/S0033291702007018
– volume: 214
  start-page: 911
  year: 2011
  ident: 4497_CR18
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-010-2102-6
– volume: 753
  start-page: 32
  year: 2015
  ident: 4497_CR26
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2014.07.046
– volume: 71
  start-page: 341
  year: 2002
  ident: 4497_CR40
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/S0091-3057(01)00693-1
– volume: 166
  start-page: 1178
  year: 2009
  ident: 4497_CR15
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2009.09020149
– volume: 30
  start-page: 563
  year: 2009
  ident: 4497_CR36
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2009.09.002
– volume: 42
  start-page: 1118
  year: 2008
  ident: 4497_CR37
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2008.05.049
– volume: 33
  start-page: 689
  year: 2016
  ident: 4497_CR2
  publication-title: Depression and anxiety
  doi: 10.1002/da.22501
– volume: 3
  start-page: 13
  year: 2009
  ident: 4497_CR30
  publication-title: Front Syst Neurosci
  doi: 10.3389/neuro.06.013.2009
– volume: 93
  start-page: 296
  year: 2007
  ident: 4497_CR38
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.03.010
– volume: 36
  start-page: 308
  year: 2011
  ident: 4497_CR29
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2010.05.003
– volume: 55
  start-page: 328
  year: 2016
  ident: 4497_CR19
  publication-title: J Am Acad Child Adolesc Psychiatry
  doi: 10.1016/j.jaac.2016.01.007
– volume: 23
  start-page: 1414
  year: 2013
  ident: 4497_CR12
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2013.03.002
– volume: 22
  start-page: 4563
  year: 2002
  ident: 4497_CR6
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-11-04563.2002
– volume: 63
  start-page: 1012
  year: 2012
  ident: 4497_CR16
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2012.07.025
– volume: 17
  start-page: 1321
  year: 2014
  ident: 4497_CR25
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145714000649
– volume: 68
  start-page: 118
  year: 2010
  ident: 4497_CR10
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.01.027
– volume: 160
  start-page: 990
  year: 2003
  ident: 4497_CR14
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.160.5.990
– volume: 34
  start-page: 4618
  year: 2014
  ident: 4497_CR7
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5058-13.2014
– volume: 19
  start-page: 1898
  year: 2013
  ident: 4497_CR34
  publication-title: Curr Pharm Des
  doi: 10.2174/13816128113199990293
– volume: 118
  start-page: 3
  year: 2013
  ident: 4497_CR39
  publication-title: Ups J Med Sci
  doi: 10.3109/03009734.2012.724118
SSID ssj0000484
ssj0068394
Score 2.328014
Snippet Rationale Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using...
Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using the...
Rationale Depression is characterized by an excessive attribution of value to negative feedback. This imbalance in feedback sensitivity can be measured using...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 613
SubjectTerms Analysis
Animals
Antidepressants
Antidepressive Agents - pharmacology
Attributional biases
Biomedical and Life Sciences
Biomedicine
Depression (Mood disorder)
Dosage and administration
Dose-Response Relationship, Drug
Drug therapy
Feedback
Feedback (Communication)
Ketamine
Ketamine - pharmacology
Male
Neurosciences
Original Investigation
Pharmacological research
Pharmacology/Toxicology
Physiological aspects
Psychiatry
Psychopharmacology
Rats
Rats, Sprague-Dawley
Reversal Learning - drug effects
Studies
SummonAdditionalLinks – databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB-kgvgitn5Fq6wgFbTB5PYreSyHpSiVPrTQt7BfqaXXnDS5h_73ndnkcr1DCz6GnQ2bzMzOb5nZ3wB8ChiTlfE6dcLLFDc8iy4VQorIgPI6XoTI3Xn8Sx2diR_n8nwgi6a7MBv5-2-xaxJV_KhUiFKneNB5LHOuqUvDVE1Xm66g-5b9g8Kg37Mvc7o7JotlNvNv71uLR5u78r2wtFkyuZE3jeHo8Dk8G3AkO-gVvw2PQrMDT46HTPkO7J30nNS3--x0dcWq3Wd77GTFVn37AhY_Q2eucQ7zEUG2oWUtVbX3bSXYvGbXuFyGltKybs7QLmZ94T1rwkWkDWc1hkBr3BW7bJhh1KMm8vYSBTQjiqib1szSoT_FBetMe_USzg6_n06P0qEXQ-qkzjp0JqcIXBRECOczVddlwEBmtdfOelVqqU3pvVF4gDOeCxVyK_ikUDVagkOY8gq2mnkT3gBzeCKvjcDjMMqVhlvNyyKYzGbaljy3CWRLjVRuICqnfhmzaqRYjkqsqDiNlFjlCXwZp_zpWToeEv5Maq7Ig_G9zgwXEXB1xIVVHUhiGaQeJAnsrkniH3brw0tDqQbPb6u8UBIxIy9UAh_HYZpJ1WxNmC9IRmjEiTLXD8mgGSOcF1kCr3vbGz9tgpsq50omoNeschQgzvD1kebyd-QOl8TPnxUJfF3a772l_-uPvf0v6XfwdELYJ5a278JWd7MI7xG5dfZD9Nk7wXE33w
  priority: 102
  providerName: Springer Nature
Title Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task
URI https://link.springer.com/article/10.1007/s00213-016-4497-1
https://www.ncbi.nlm.nih.gov/pubmed/27933365
https://www.proquest.com/docview/1865251386
https://www.proquest.com/docview/1847893517
https://www.proquest.com/docview/1868308040
https://pubmed.ncbi.nlm.nih.gov/PMC5263208
Volume 234
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED62FsZextb98tYVDUYHW83sWJbsp5GEZGWlIYwGsicjS3JXmjpd7Tz0v9-d7CRNYHmJCToZ2fp0d_KdvgP4ZNEmC2Wkr7mJfVR4OS4pa330DCiuY7h13J3nI3E64T-n8bT94Fa1aZVLnegUtZlr-kb-LUxEjLY4SsT3278-VY2i6GpbQuMx7BN1GaFaTuVaE3M6hNn8EegJNJTMER0oi5NliDNwjKIdKnIQCp_zVPrhhpHaVtUPbNV2HuVWMNXZqOFzeNY6l6zboOEFPLLlATw5b8PnB3A8boiq70_YxfrcVXXCjtl4TWF9_xIWZ7ZWN9iHGedWVrZiFaW6N7Um2LxgNzhchvCpWD1nCJZZk43PSnvpuMRZgXYxV_qaXZVMMSpc48h8iReaEW_UXaVmflu04pLVqrp-BZPh4KJ_6rcFGnwdy6DGFaYFeRwJscSZQBRFatG65dJInRuRyliq1BglcFenTMSFDXMedRJRIDw0-i6vYa-cl_YtMI3b9EJx3COjXKqiXEZpYlWQBzJPozD3IFjOSKZb9nIqojHLVrzLbhIzylijScxCD76sutw21B27hD_TNGe0rPG-WrWnE3B0RJCVdWOiHqTCJB4cbkjiG9abzUugZK06qLI1eD34uGqmnpTiVtr5gmS4ROcxDuUuGYQx-vg88OBNg73Vo3VQ00aRiD2QG6hcCRCR-GZLefXHEYrHRNofJB58XeL3wdD_98be7X7Q9_C0Qx6QS3A_hL36bmE_oP9W50dukR7BfnfY643o-uP32QCvvcFo_Atb-6KPv5NO9x-cgUYC
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQEvCMZXYICRYEiwiHw4dvKA0ARMHV2nPXRS34LjOGNal44lFeo_xd_InZO0ayX6tsfI58jOne_OubvfAbw1aJOFyqWreR65qPAyPFLGuOgZUFwn58Zidw6ORO-E_xhFow3429XCUFplpxOtos4nmv6Rf_JjEaEtDmPx5fK3S12jKLratdBoxKJvZn_wylZ9PviG_H0XBPvfh197bttVwNWR9GoUCy3ITMYEbZZ7oigSgyo5k7nUWS4SGUmV5LkSeBVReciF8TMeBrEocE8aDS6-9xbcRsPr0WVPjuRC83Mq-mweBHoeDQR0SAVsUdyFVD2LYBpQUwVfuJwn0vWXjOKqabhmG1fzNleCt9Ym7j-A-60zy_Ya6XsIG6bcgjuDNly_BTvHDTD2bJcNF3Ve1S7bYccLyOzZI5j2Ta0ucA7LrRtbmYpVlFrf9LZgk4Jd4HIZimvF6glD4Rw32f-sNKcWu5wVaIczpc_ZWckUo0Y5FjyYcKgZ4VRdVWrstk0yTlmtqvPHcHIjrHsCm-WkNM-AaS6SQnG8kyNdosJMhklslJd5MktCP3PA6ziS6hYtnZp2jNM5zrNlYkoZcsTE1Hfgw3zKZQMVso74PbE5JTWC79WqrYbA1REgV7oXEdQhNUJxYHuJEr-wXh7uBCVt1U-VLg6LA2_mwzSTUupKM5kSDZforEa-XEeDYox3Cu458LSRvfnWAtTsYSgiB-SSVM4JCLh8eaQ8-2UBzCNqEuDFDnzs5Pfa0v_3xZ6v3-hruNsbDg7Tw4Oj_gu4F5D3ZZPrt2Gzvpqal-g71tkre2AZ_LxpDfEPWpF7sQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEJ_gkRBfDOJXBXVNFBOloR_b3fbBGBQu4MnlYiDhrWy3WyQcPaS9mPvX_Ouc6ccdd4n3xmOzs81uZ3ZmtjPzG4B3Bm2yUKm0NU8DGxVegkfKGBs9A4rrpNxU2J3HfXF4yr-fBWcr8LethaG0ylYnVoo6HWn6R77rhiJAW-yHYjdr0iIG-90vN79t6iBFkda2nUYtIj0z-YPXt-Lz0T7y-r3ndQ9Ovh3aTYcBWwfSKVFEtCCTGRLMWeqILIsMqudEplInqYhkIFWUpkrgtUSlPhfGTbjvhSLD_Wk0vvjeB7Aq6VbUgdWvB_3Bz5kd4FQCWj8I9ENqQGifytmCsA2wOhWeqUctFlxhcx5J250zkYuG4o6lXMziXAjlVhayuw6PGteW7dWy-BhWTL4Ba8dN8H4Dtgc1TPZkh53Mqr6KHbbNBjMA7ckTGPdMqa5xDksrp7YwBSso0b7udMFGGbvG5TIU3oKVI4aiOqxrAVhuLiokc5ahVU6UvmKXOVOM2uZUUMKESs0Iteq2UEO7aZlxwUpVXD2F03th3jPo5KPcvACmuYgyxfGGjnSR8hPpR6FRTuLIJPLdxAKn5UisG-x0auExjKeozxUTY8qXIybGrgUfp1NuauCQZcQfiM0xKRV8r1ZNbQSujuC54r2AgA-pLYoFW3OU-IX1_HArKHGjjIp4dnQseDsdppmUYJeb0ZhouETXNXDlMhoUY7xhcMeC57XsTbfmoZ73fRFYIOekckpAMObzI_nlrwrOPKCWAU5owadWfu8s_X9f7OXyjb6BNdQO8Y-jfm8THnrkilWZ9lvQKW_H5hU6kmXyujmxDM7vW0n8A-nBgUw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ketamine+decreases+sensitivity+of+male+rats+to+misleading+negative+feedback+in+a+probabilistic+reversal-learning+task&rft.jtitle=Psychopharmacology+%28Berlin%2C+Germany%29&rft.au=Rychlik%2C+Michal&rft.au=Bollen%2C+Eva&rft.au=Rygula%2C+Rafal&rft.date=2017-02-01&rft.issn=1432-2072&rft.eissn=1432-2072&rft.volume=234&rft.issue=4&rft.spage=613&rft_id=info:doi/10.1007%2Fs00213-016-4497-1&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon